Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Celltrion Partners with the Canadian Biotech Company, iProgen Biotech to Develop a Series of Novel ADCs
Monday, April 08, 2019Celltrion and the Canadabased iProgen Biotech Inc announced to agree to partner for the development of novel ADCs against validated antibody targets including HER and CD The terms of the partnership agreement include Celltrion manufactures and su...
Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia
Friday, April 05, 2019Sinovant Sciences and Roivant Sciences today announced the launch of Cytovant Sciences a biopharmaceutical company focused on developing and commercializing innovative cellular therapeutics in Asia Cytovant will focus on development programs that hav...
Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use
Friday, April 05, 2019Orgenesis Inc a developer manufacturer and service provider of advanced cell therapies today announced that it has entered into a collaboration agreement with Digilab Inc to develop a live cell printing process and systems designed to automate the pr...
Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug
Thursday, April 04, 2019Clinigen KK and GC Pharma today announced an exclusive licensing agreement in Japan to commercialize Hunterase Idursulfasebeta ICV a human recombinant iduronatesulfatase IDS used in enzyme replacement therapy for the treatment of Hunter syndrome Used...
Cellgen Diagnostics and Genomic Testing Cooperative Partner to Establish a New Standard in Co-Development of Companion Diagnostics for Cancer Therapies
Thursday, April 04, 2019Cellgen Diagnostics a leading precision diagnostics company and Genomic Testing Cooperative GTC a pioneer in molecular testing today announced a strategic collaboration to help accelerate global development of companion tests for various oncology the...
Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement
Thursday, April 04, 2019Editas Medicine Inc a leading genome editing company and BlueRock Therapeutics LP a leading engineered cell therapy company today announced a strategic research collaboration and crosslicensing agreement to combine their respective genome editing and...
Xencor and Astellas Enter Collaboration for Novel Bispecific Antibody Program
Wednesday, April 03, 2019Xencor Inc a clinicalstage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer autoimmune disease asthma and allergic diseases today announced it has entered into a research and license agreement in which...
BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
Wednesday, April 03, 2019BriaCell Therapeutics Corp a clinicalstage biotechnology company specializing in targeted immunotherapy for advanced breast cancer today announced a clinical trial collaboration and supply agreement the Agreement with Incyte a global biopharmaceutic...
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole
Tuesday, April 02, 2019Pulmatrix Inc a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease announced today its entry into a Binding Term Sheet with Cipla Technologies LLC Cip Tec a subsidiary...
Puma Biotechnology and Pierre Fabre enter into an exclusive license agreement for the development and marketing of NERLYNX® (neratinib)
Tuesday, April 02, 2019Puma Biotechnology Inc and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and market NERLYNX neratinib in Europe and in some regions of Africa In September the European Commission granted the mark...
